An effectiveness and safety study of herbal extract product comparing to standard treatment in male and female androgenetic alopecia
Phase 4
Completed
- Conditions
- An effectiveness and safety study of herbal extract product comparing to standard treatment in male and female androgenetic alopeciaAndrogenetic alopecia
- Registration Number
- TCTR20220927001
- Lead Sponsor
- Srinakharinwirot University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Male (Norwood-Hamilton classification of IIa - V)
Females (Ludwig classification of I-4, II-1, II-2)
No history of allergic reaction following study topical drug used
Older than 18 years
Exclusion Criteria
-Used the following medications within 6 months prior to screening : minoxidil, finasteride, medication with anti-androgenic properties, estrogen, progesterone, tamoxifen, anabolic steroid and oral contraceptive drugs.
-Hair transplant within 1 year
-Pregnancy
-Breast feeding
-Abnormal thyroid function test
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy and safety 6 months Terminal hair/Hair mass index/ 7 rating scalr score/ Pateint-self assessment
- Secondary Outcome Measures
Name Time Method efficacy 6 months hair count/ clinical assessment